Denali Therapeutics (DNLI) Return on Assets (2018 - 2024)
Historic Return on Assets for Denali Therapeutics (DNLI) over the last 8 years, with Q3 2025 value amounting to 0.1%.
- Denali Therapeutics' Return on Assets rose 1900.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year increase of 1900.0%. This contributed to the annual value of 0.33% for FY2024, which is 2200.0% down from last year.
- According to the latest figures from Q3 2025, Denali Therapeutics' Return on Assets is 0.1%, which was up 1900.0% from 0.18% recorded in Q2 2025.
- In the past 5 years, Denali Therapeutics' Return on Assets registered a high of 0.04% during Q1 2021, and its lowest value of 0.3% during Q4 2024.
- Moreover, its 5-year median value for Return on Assets was 0.2% (2021), whereas its average is 0.16%.
- Examining YoY changes over the last 5 years, Denali Therapeutics' Return on Assets showed a top increase of 3800bps in 2021 and a maximum decrease of -2600bps in 2021.
- Over the past 5 years, Denali Therapeutics' Return on Assets (Quarter) stood at 0.2% in 2021, then dropped by -20bps to 0.24% in 2022, then skyrocketed by 50bps to 0.12% in 2023, then crashed by -146bps to 0.3% in 2024, then skyrocketed by 65bps to 0.1% in 2025.
- Its last three reported values are 0.1% in Q3 2025, 0.18% for Q2 2025, and 0.24% during Q1 2025.